AsttraZeneca Pharmaceuticals LP recalls Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation can…
- Recall date
- May 14, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0444-2025
- FDA classification
- Class II
- Brand / firm
- AsttraZeneca Pharmaceuticals LP
- Sold / distributed
- USA Nationwide
Why it was recalled
Defective delivery system
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .
Get recall alerts
Free email alert whenever AsttraZeneca Pharmaceuticals LP has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AsttraZeneca Pharmaceuticals LP